Andrew Obenshain
2022
In 2022, Andrew Obenshain earned a total compensation of $1.8M as Chief Executive Officer at bluebird bio, a 80% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $386,280 |
|---|---|
| Option Awards | $421,830 |
| Salary | $643,390 |
| Stock Awards | $351,000 |
| Other | $12,200 |
| Total | $1,814,700 |
Obenshain received $643.4K in salary, accounting for 35% of the total pay in 2022.
Obenshain also received $386.3K in non-equity incentive plan, $421.8K in option awards, $351K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Andrew Obenshain's compensation ranked 1,918th out of 5,760 executives tracked by ExecPay. In other words, Obenshain earned more than 66.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,918 out of 5,760 | 67th |
Division Manufacturing | 1,020 out of 3,136 | 68th |
Major group Chemicals And Allied Products | 430 out of 1,422 | 70th |
Industry group Drugs | 395 out of 1,323 | 70th |
Industry Biological Products, Except Diagnostic Substances | 98 out of 291 | 66th |
Source: SEC filing on April 28, 2023.
Obenshain's colleagues
We found three more compensation records of executives who worked with Andrew Obenshain at bluebird bio in 2022.